Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study of Lung Cancer Screening in the Flemish Region, the ZORALCS Study

NCT06293833 is registered in ClinicalTrials.gov with University Hospital, Antwerp as lead sponsor.

NCT NCT06293833
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06293833 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study of Lung Cancer Screening in the Flemish Region, the ZORALCS Study
Lead sponsor
University Hospital, Antwerp
Phase
Not applicable
Overall status
Unknown status
Start date
September 1, 2024
Completion date
January 1, 2026
Enrollment
700 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, lung cancer, nonsmall cell, lung cancer, small cell, smoking cessation